Comparison of edoxaban and enoxaparin in a rat model of AlCl<sub>3</sub>-induced thrombosis of the superior sagittal sinus.
Journal Information
Full Title: Naunyn Schmiedebergs Arch Pharmacol
Abbreviation: Naunyn Schmiedebergs Arch Pharmacol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Competing interestsT Braun and M Yeniguen report financial support from Daiichi Sankyo Co., Ltd. for the conduct of the study. The funding had no influence on the conduction or results of the study. All other authors report no conflicts of interest. Ethical approvalAll applicable international, national, and institutional guidelines for the care and use of animals were followed. All procedures were conducted in accordance with our institutional guidelines and the German animal protection legislation and were approved by the regional ethics committee (Regierungspraesidium Darmstadt: Az. B10/1000). Conflict of interestT. Braun and M. Yeniguen report financial support from Daiichi Sankyo Co., Ltd. for the conduct of the study. The funding had no influence on the conduction or results of the study. All other authors report no conflicts of interest. Competing interests T Braun and M Yeniguen report financial support from Daiichi Sankyo Co., Ltd. for the conduct of the study. The funding had no influence on the conduction or results of the study. All other authors report no conflicts of interest. Conflict of interest T. Braun and M. Yeniguen report financial support from Daiichi Sankyo Co., Ltd. for the conduct of the study. The funding had no influence on the conduction or results of the study. All other authors report no conflicts of interest."
"Funding Open Access funding enabled and organized by Projekt DEAL. This study was supported by Daiichi Sankyo Co., Ltd."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025